schliessen

Filtern

 

Bibliotheken

Genetics of Common Endocrine Disease: The Present and the Future

Context: In honor of the 75th issue of the Journal of Clinical Endocrinology and Metabolism, the author was invited to present his perspectives on genetics in human endocrinology. This paper reviews what the field has achieved in the genetics of common endocrine disease, and offers predictions on wh... Full description

Journal Title: The journal of clinical endocrinology and metabolism 2016, Vol.101 (3), p.787-794
Main Author: Goodarzi, Mark O
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: United States: Endocrine Society
ID: ISSN: 0021-972X
Link: https://www.ncbi.nlm.nih.gov/pubmed/26908105
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4803177
title: Genetics of Common Endocrine Disease: The Present and the Future
format: Article
creator:
  • Goodarzi, Mark O
subjects:
  • 75th Anniversary
  • 75th Anniversary Articles
  • Abridged Index Medicus
  • Endocrine System Diseases - classification
  • Endocrine System Diseases - genetics
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Humans
  • Polymorphism, Single Nucleotide
ispartof: The journal of clinical endocrinology and metabolism, 2016, Vol.101 (3), p.787-794
description: Context: In honor of the 75th issue of the Journal of Clinical Endocrinology and Metabolism, the author was invited to present his perspectives on genetics in human endocrinology. This paper reviews what the field has achieved in the genetics of common endocrine disease, and offers predictions on where the field will move in the future and its impact on endocrine clinical practice. Evidence Acquisition: The October 2015 data release of the National Human Genome Research Institute-European Bioinformatics Institute (NHGRI-EBI) Catalog of Published Genome-wide Association Studies was queried regarding endocrinologic diseases and traits. PubMed searches were focused on genetic prediction of disease, genetic findings and drug targets, functional interrogation of genetic loci, use of genetics to subtype disease, missing heritability, systems genomics, and higher order chromatin structures as regulators of gene function. Evidence Synthesis: Nearly a quarter of genome wide association study findings concern endocrinologic diseases and traits. While these findings have not yet dramatically altered clinical care, genetics will have a major impact by providing the drug targets of tomorrow, facilitated by experimental and bioinformatic advances that will shorten the time from gene discovery to drug development. Use of genetic findings to subtype common endocrine disease will allow more precise prevention and treatment efforts. Future advances will allow us to move away from the common view of DNA as a string of letters, allowing exploration of higher order structure that likely explains much “missing heritability.” Conclusions: The future will see a greater role of genetics at the bedside, with genetic epidemiologic discoveries leading not only to new treatments of endocrine disease, but also helping us prescribe the right drug to the right patients by allowing subclassification of common heterogeneous endocrine conditions. Future technological breakthroughs will reveal the heritable mysteries hidden in chromatin structure, leading to a more complete characterization of heritability that will propel our ability to translate genetic findings into new preventions and treatments.
language: eng
source:
identifier: ISSN: 0021-972X
fulltext: no_fulltext
issn:
  • 0021-972X
  • 1945-7197
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.475001
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4803177
sourceformatXML
sourcesystemPC
sourcerecordid1770878892
originalsourceidFETCH-LOGICAL-14444-d75af8927f14f9e70af908d19f210276e57c5fab9891f55efdabf7bad9d0c0c00
addsrcrecordideNptUU1v1DAUtBCILoUbZ5QjB1Ls-JsDAi39QKoEhyJxsxz7mc2Stbd2QsW_x0vaikrYB-vZM_PmeRB6SfAJ6Qh-u3UnHSa8pYLhR2hFNOOtJFo-RiuMO9Jq2X0_Qs9K2WJMGOP0KTrqhMaKYL5CH84hwjS40qTQrNNul2JzGn1yeYjQfBoK2ALvmqsNNF8zFIhTY6NvplqfzdOc4Tl6EuxY4MXteYy-nZ1erS_ayy_nn9cfL9vak7HWS26D0p0MhAUNEttQLXiiQ52hkwK4dDzYXitNAucQvO2D7K3XHru68TF6v-ju534H3lUn2Y5mn4edzb9NsoN5-BKHjfmRfhmmMCVSVoGLRSDtIdohwwOur79gkjedkMb1VAkqg7JCiF4wQaj3FFNmFRfa2ir1-tZLTtczlMnshuJgHG2ENBdzaKekquNW6JsF6nIqJUO470qwOeRnts4c8jOH_Cr81b9T3oPvAqsAtgBu0jhBLj_H-Qay2YAdp43BdTEhVVsVBaa1av9eVRpdaHCX7b6mWcw2zTnW2P7v5g9_Y7Ud
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1770878892
display
typearticle
titleGenetics of Common Endocrine Disease: The Present and the Future
creatorGoodarzi, Mark O
creatorcontribGoodarzi, Mark O
descriptionContext: In honor of the 75th issue of the Journal of Clinical Endocrinology and Metabolism, the author was invited to present his perspectives on genetics in human endocrinology. This paper reviews what the field has achieved in the genetics of common endocrine disease, and offers predictions on where the field will move in the future and its impact on endocrine clinical practice. Evidence Acquisition: The October 2015 data release of the National Human Genome Research Institute-European Bioinformatics Institute (NHGRI-EBI) Catalog of Published Genome-wide Association Studies was queried regarding endocrinologic diseases and traits. PubMed searches were focused on genetic prediction of disease, genetic findings and drug targets, functional interrogation of genetic loci, use of genetics to subtype disease, missing heritability, systems genomics, and higher order chromatin structures as regulators of gene function. Evidence Synthesis: Nearly a quarter of genome wide association study findings concern endocrinologic diseases and traits. While these findings have not yet dramatically altered clinical care, genetics will have a major impact by providing the drug targets of tomorrow, facilitated by experimental and bioinformatic advances that will shorten the time from gene discovery to drug development. Use of genetic findings to subtype common endocrine disease will allow more precise prevention and treatment efforts. Future advances will allow us to move away from the common view of DNA as a string of letters, allowing exploration of higher order structure that likely explains much “missing heritability.” Conclusions: The future will see a greater role of genetics at the bedside, with genetic epidemiologic discoveries leading not only to new treatments of endocrine disease, but also helping us prescribe the right drug to the right patients by allowing subclassification of common heterogeneous endocrine conditions. Future technological breakthroughs will reveal the heritable mysteries hidden in chromatin structure, leading to a more complete characterization of heritability that will propel our ability to translate genetic findings into new preventions and treatments.
identifier
0ISSN: 0021-972X
1EISSN: 1945-7197
2DOI: 10.1210/jc.2015-3640
3PMID: 26908105
languageeng
publisherUnited States: Endocrine Society
subject75th Anniversary ; 75th Anniversary Articles ; Abridged Index Medicus ; Endocrine System Diseases - classification ; Endocrine System Diseases - genetics ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Polymorphism, Single Nucleotide
ispartofThe journal of clinical endocrinology and metabolism, 2016, Vol.101 (3), p.787-794
rights
0Copyright © 2016 by the Endocrine Society
1Copyright © 2016 by The Endocrine Society
2Copyright © 2016 by the Endocrine Society 2016
lds50peer_reviewed
oafree_for_read
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26908105$$D View this record in MEDLINE/PubMed
search
creatorcontribGoodarzi, Mark O
title
0Genetics of Common Endocrine Disease: The Present and the Future
1The journal of clinical endocrinology and metabolism
addtitleJ Clin Endocrinol Metab
descriptionContext: In honor of the 75th issue of the Journal of Clinical Endocrinology and Metabolism, the author was invited to present his perspectives on genetics in human endocrinology. This paper reviews what the field has achieved in the genetics of common endocrine disease, and offers predictions on where the field will move in the future and its impact on endocrine clinical practice. Evidence Acquisition: The October 2015 data release of the National Human Genome Research Institute-European Bioinformatics Institute (NHGRI-EBI) Catalog of Published Genome-wide Association Studies was queried regarding endocrinologic diseases and traits. PubMed searches were focused on genetic prediction of disease, genetic findings and drug targets, functional interrogation of genetic loci, use of genetics to subtype disease, missing heritability, systems genomics, and higher order chromatin structures as regulators of gene function. Evidence Synthesis: Nearly a quarter of genome wide association study findings concern endocrinologic diseases and traits. While these findings have not yet dramatically altered clinical care, genetics will have a major impact by providing the drug targets of tomorrow, facilitated by experimental and bioinformatic advances that will shorten the time from gene discovery to drug development. Use of genetic findings to subtype common endocrine disease will allow more precise prevention and treatment efforts. Future advances will allow us to move away from the common view of DNA as a string of letters, allowing exploration of higher order structure that likely explains much “missing heritability.” Conclusions: The future will see a greater role of genetics at the bedside, with genetic epidemiologic discoveries leading not only to new treatments of endocrine disease, but also helping us prescribe the right drug to the right patients by allowing subclassification of common heterogeneous endocrine conditions. Future technological breakthroughs will reveal the heritable mysteries hidden in chromatin structure, leading to a more complete characterization of heritability that will propel our ability to translate genetic findings into new preventions and treatments.
subject
075th Anniversary
175th Anniversary Articles
2Abridged Index Medicus
3Endocrine System Diseases - classification
4Endocrine System Diseases - genetics
5Genetic Predisposition to Disease
6Genome-Wide Association Study
7Humans
8Polymorphism, Single Nucleotide
issn
00021-972X
11945-7197
fulltextfalse
rsrctypearticle
creationdate2016
recordtypearticle
recordideNptUU1v1DAUtBCILoUbZ5QjB1Ls-JsDAi39QKoEhyJxsxz7mc2Stbd2QsW_x0vaikrYB-vZM_PmeRB6SfAJ6Qh-u3UnHSa8pYLhR2hFNOOtJFo-RiuMO9Jq2X0_Qs9K2WJMGOP0KTrqhMaKYL5CH84hwjS40qTQrNNul2JzGn1yeYjQfBoK2ALvmqsNNF8zFIhTY6NvplqfzdOc4Tl6EuxY4MXteYy-nZ1erS_ayy_nn9cfL9vak7HWS26D0p0MhAUNEttQLXiiQ52hkwK4dDzYXitNAucQvO2D7K3XHru68TF6v-ju534H3lUn2Y5mn4edzb9NsoN5-BKHjfmRfhmmMCVSVoGLRSDtIdohwwOur79gkjedkMb1VAkqg7JCiF4wQaj3FFNmFRfa2ir1-tZLTtczlMnshuJgHG2ENBdzaKekquNW6JsF6nIqJUO470qwOeRnts4c8jOH_Cr81b9T3oPvAqsAtgBu0jhBLj_H-Qay2YAdp43BdTEhVVsVBaa1av9eVRpdaHCX7b6mWcw2zTnW2P7v5g9_Y7Ud
startdate201603
enddate201603
creatorGoodarzi, Mark O
general
0Endocrine Society
1Copyright by The Endocrine Society
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
87X8
9BOBZL
10CLFQK
115PM
sort
creationdate201603
titleGenetics of Common Endocrine Disease: The Present and the Future
authorGoodarzi, Mark O
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-14444-d75af8927f14f9e70af908d19f210276e57c5fab9891f55efdabf7bad9d0c0c00
rsrctypearticles
prefilterarticles
languageeng
creationdate2016
topic
075th Anniversary
175th Anniversary Articles
2Abridged Index Medicus
3Endocrine System Diseases - classification
4Endocrine System Diseases - genetics
5Genetic Predisposition to Disease
6Genome-Wide Association Study
7Humans
8Polymorphism, Single Nucleotide
toplevelpeer_reviewed
creatorcontribGoodarzi, Mark O
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7MEDLINE - Academic
8OpenAIRE (Open Access)
9OpenAIRE
10PubMed Central (Full Participant titles)
jtitleThe journal of clinical endocrinology and metabolism
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
auGoodarzi, Mark O
formatjournal
genrearticle
ristypeJOUR
atitleGenetics of Common Endocrine Disease: The Present and the Future
jtitleThe journal of clinical endocrinology and metabolism
addtitleJ Clin Endocrinol Metab
seriestitlePerspectives in Endocrinology
date2016-03
risdate2016
volume101
issue3
spage787
epage794
pages787-794
issn0021-972X
eissn1945-7197
notesThis work was supported by National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center Grant P30-DK063491 (to the Southern California Diabetes Research Center).
abstractContext: In honor of the 75th issue of the Journal of Clinical Endocrinology and Metabolism, the author was invited to present his perspectives on genetics in human endocrinology. This paper reviews what the field has achieved in the genetics of common endocrine disease, and offers predictions on where the field will move in the future and its impact on endocrine clinical practice. Evidence Acquisition: The October 2015 data release of the National Human Genome Research Institute-European Bioinformatics Institute (NHGRI-EBI) Catalog of Published Genome-wide Association Studies was queried regarding endocrinologic diseases and traits. PubMed searches were focused on genetic prediction of disease, genetic findings and drug targets, functional interrogation of genetic loci, use of genetics to subtype disease, missing heritability, systems genomics, and higher order chromatin structures as regulators of gene function. Evidence Synthesis: Nearly a quarter of genome wide association study findings concern endocrinologic diseases and traits. While these findings have not yet dramatically altered clinical care, genetics will have a major impact by providing the drug targets of tomorrow, facilitated by experimental and bioinformatic advances that will shorten the time from gene discovery to drug development. Use of genetic findings to subtype common endocrine disease will allow more precise prevention and treatment efforts. Future advances will allow us to move away from the common view of DNA as a string of letters, allowing exploration of higher order structure that likely explains much “missing heritability.” Conclusions: The future will see a greater role of genetics at the bedside, with genetic epidemiologic discoveries leading not only to new treatments of endocrine disease, but also helping us prescribe the right drug to the right patients by allowing subclassification of common heterogeneous endocrine conditions. Future technological breakthroughs will reveal the heritable mysteries hidden in chromatin structure, leading to a more complete characterization of heritability that will propel our ability to translate genetic findings into new preventions and treatments.
copUnited States
pubEndocrine Society
pmid26908105
doi10.1210/jc.2015-3640
oafree_for_read